iRhythm Technologies (IRTC) Competitors $135.94 +1.23 (+0.91%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$135.56 -0.38 (-0.28%) As of 07/11/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock IRTC vs. SOLV, SNN, PEN, STVN, GKOS, BLCO, NARI, TMDX, SLNO, and INSPShould you be buying iRhythm Technologies stock or one of its competitors? The main competitors of iRhythm Technologies include Solventum (SOLV), Smith & Nephew SNATS (SNN), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Bausch + Lomb (BLCO), Inari Medical (NARI), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), and Inspire Medical Systems (INSP). These companies are all part of the "medical equipment" industry. iRhythm Technologies vs. Its Competitors Solventum Smith & Nephew SNATS Penumbra Stevanato Group Glaukos Bausch + Lomb Inari Medical TransMedics Group Soleno Therapeutics Inspire Medical Systems Solventum (NYSE:SOLV) and iRhythm Technologies (NASDAQ:IRTC) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, profitability, dividends, media sentiment and analyst recommendations. Do analysts rate SOLV or IRTC? Solventum presently has a consensus price target of $81.50, suggesting a potential upside of 10.51%. iRhythm Technologies has a consensus price target of $138.60, suggesting a potential upside of 1.96%. Given Solventum's higher possible upside, analysts clearly believe Solventum is more favorable than iRhythm Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Solventum 1 Sell rating(s) 7 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.18iRhythm Technologies 0 Sell rating(s) 1 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.90 Is SOLV or IRTC more profitable? Solventum has a net margin of 4.55% compared to iRhythm Technologies' net margin of -15.90%. Solventum's return on equity of 31.01% beat iRhythm Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Solventum4.55% 31.01% 6.53% iRhythm Technologies -15.90%-101.04%-9.55% Which has more risk and volatility, SOLV or IRTC? Solventum has a beta of 0.55, meaning that its stock price is 45% less volatile than the S&P 500. Comparatively, iRhythm Technologies has a beta of 1.41, meaning that its stock price is 41% more volatile than the S&P 500. Does the media refer more to SOLV or IRTC? In the previous week, iRhythm Technologies had 8 more articles in the media than Solventum. MarketBeat recorded 14 mentions for iRhythm Technologies and 6 mentions for Solventum. iRhythm Technologies' average media sentiment score of 0.82 beat Solventum's score of 0.61 indicating that iRhythm Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Solventum 3 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive iRhythm Technologies 5 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable earnings & valuation, SOLV or IRTC? Solventum has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Solventum, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSolventum$8.25B1.55$478M$2.1634.14iRhythm Technologies$591.84M7.33-$113.29M-$3.14-43.29 SummarySolventum beats iRhythm Technologies on 8 of the 14 factors compared between the two stocks. Get iRhythm Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for IRTC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IRTC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IRTC vs. The Competition Export to ExcelMetriciRhythm TechnologiesMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.34B$1.95B$5.55B$9.09BDividend YieldN/AN/A5.07%4.03%P/E Ratio-43.2934.5628.2520.31Price / Sales7.3315.80432.0999.72Price / CashN/A54.0226.2427.98Price / Book46.888.368.125.50Net Income-$113.29M-$62.39M$3.19B$250.38M7 Day Performance-4.51%5.08%3.62%4.79%1 Month Performance-5.50%10.63%5.98%9.59%1 Year Performance41.32%5.72%29.39%16.41% iRhythm Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IRTCiRhythm Technologies1.0402 of 5 stars$135.94+0.9%$138.60+2.0%+41.3%$4.34B$591.84M-43.292,000SOLVSolventum0.6267 of 5 stars$76.24-2.9%$81.50+6.9%+50.5%$13.58B$8.25B14.3822,000SNNSmith & Nephew SNATS3.045 of 5 stars$29.95-1.1%$28.00-6.5%+6.7%$13.26B$5.81B13.8717,349News CoverageGap DownPENPenumbra4.7677 of 5 stars$248.05-1.2%$302.40+21.9%+24.4%$9.72B$1.19B234.014,500News CoverageAnalyst ForecastInsider TradeSTVNStevanato Group1.1819 of 5 stars€24.23-1.5%N/A+15.9%€7.34B€1.19B47.515,521Positive NewsGKOSGlaukos4.3424 of 5 stars$101.69-1.7%$134.67+32.4%-14.3%$5.91B$383.48M-42.91780BLCOBausch + Lomb3.0612 of 5 stars$13.83-0.4%$15.54+12.4%-12.9%$4.91B$4.79B28.9213,500Analyst ForecastNARIInari Medical0.2649 of 5 stars$79.97flat$69.22-13.4%N/A$4.68B$493.63M-59.24800News CoverageTMDXTransMedics Group2.2587 of 5 stars$125.17-3.1%$127.33+1.7%-20.9%$4.37B$441.54M94.99210News CoveragePositive NewsAnalyst RevisionSLNOSoleno Therapeutics4.6202 of 5 stars$85.27-1.6%$107.10+25.6%+71.1%$4.37BN/A-18.4630Trending NewsAnalyst ForecastINSPInspire Medical Systems4.8829 of 5 stars$127.11-1.1%$211.91+66.7%-6.0%$3.79B$802.80M59.211,246News CoveragePositive NewsAnalyst Upgrade Related Companies and Tools Related Companies Solventum Alternatives Smith & Nephew SNATS Alternatives Penumbra Alternatives Stevanato Group Alternatives Glaukos Alternatives Bausch + Lomb Alternatives Inari Medical Alternatives TransMedics Group Alternatives Soleno Therapeutics Alternatives Inspire Medical Systems Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IRTC) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iRhythm Technologies Please log in to your account or sign up in order to add this asset to your watchlist. Share iRhythm Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
